Clinical Trials Update: April 22, 2009
April 23 -- (HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch and ClinicalConnection.com:
Gastroesophageal Reflux Disease (GERD)
If you are 18 to 75 with a history of GERD symptoms (e.g., acid regurgitation, dyspepsia, chest or gastric pain) for at least three months, you may qualify for this study.
The research site is in Nashville, Tenn.
More information
Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=70.
-----
Migraine and Cluster Headaches
If you are an adult with a history of chronic migraine for at least six months and are not taking any daily medication to prevent migraines other than topiramate (Topamax), you may qualify for this study evaluating two FDA-approved medications.
The research site is in Irvine, Calif.
More information
Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=100.
-----
Pain
If you have painful osteoarthritis of the hip or knee and are taking naproxen or celecoxib, you may qualify for this study.
The research site is in Raleigh, N.C.
More information
Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=834.
-----
Irritable Bowel Syndrome (IBS)
This study will evaluate an FDA-approved drug for people with non-constipation IBS. It will include eight clinic visits over 14 weeks.
The research site is in Sacramento, Calif.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/ibs.aspx.
-----
Psoriasis
If you are at least 18, have diagnosed psoriasis and are otherwise healthy, you may qualify for this study.
The research site is in Denver, Colo.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/psoriasis.aspx.
-----
Atopic Dermatitis (Eczema)
This study is evaluating an investigational ointment for atopic dermatitis. It involves three clinic visits over 15 days.
Related Stories
ABC News Live